develop small red spots on the skin that started on the upper leg; proceeded after a few days to develop an area larger than a silver dollar of 15-20 little pustules; It was seeping and itchy; It was seeping and itchy; had another one higher on the leg and developed more of those red spots over various areas of his body; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (develop small red spots on the skin that started on the upper leg), PUSTULE (proceeded after a few days to develop an area larger than a silver dollar of 15-20 little pustules), DISCHARGE (It was seeping and itchy), PRURITUS (It was seeping and itchy) and RASH (had another one higher on the leg and developed more of those red spots over various areas of his body) in a 92-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     The patient's past medical history included Hives (when the patient was 30, the patient was in the hospital for issues with hives in the colon). Concurrent medical conditions included Rash (a year ago the patient used deodorant with poly propylene glycol in it and developed a rash) since 2020 and Eye disorder NOS (Eye condition). Concomitant products included XANTOFYL, ZEAXANTHIN (I CAPS) for Eye disorder NOS, AMLODIPINE, PRAVASTATIN, TAMSULOSIN, LEVOTHYROXINE, ACETYLSALICYLIC ACID (BABY ASPIRIN), MULTIVITAMINS [VITAMINS NOS], FISH OIL and CHONDROITIN SULFATE, GLUCOSAMINE (GLUCOSAMINE CHONDROITIN [CHONDROITIN SULFATE; GLUCOSAMINE]) for an unknown indication.    On 28-Jan-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced RASH MACULAR (develop small red spots on the skin that started on the upper leg), PUSTULE (proceeded after a few days to develop an area larger than a silver dollar of 15-20 little pustules), DISCHARGE (It was seeping and itchy), PRURITUS (It was seeping and itchy) and RASH (had another one higher on the leg and developed more of those red spots over various areas of his body). At the time of the report, RASH MACULAR (develop small red spots on the skin that started on the upper leg), PUSTULE (proceeded after a few days to develop an area larger than a silver dollar of 15-20 little pustules), DISCHARGE (It was seeping and itchy), PRURITUS (It was seeping and itchy) and RASH (had another one higher on the leg and developed more of those red spots over various areas of his body) had not resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered RASH MACULAR (develop small red spots on the skin that started on the upper leg), PUSTULE (proceeded after a few days to develop an area larger than a silver dollar of 15-20 little pustules), DISCHARGE (It was seeping and itchy), PRURITUS (It was seeping and itchy) and RASH (had another one higher on the leg and developed more of those red spots over various areas of his body) to be possibly related.    No treatment medications were provided by the reporter.  The patient did not know of the warning of having a rash.   This case was linked to MOD-2021-395744 (Patient Link).